Connect Biopharma Holdings Limited announced the appointment of Chin Lee, MD, MPH, as Chief Medical Officer, effective March 1, 2022. Prior to joining the Company, Dr. Lee served as Vice President, Head of Clinical Science, and Chief Medical Officer at Theravance Biopharma Inc.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.71 USD | -2.84% | -3.39% | +44.92% |
Apr. 17 | Sector Update: Health Care Stocks Retreating Late Afternoon | MT |
Apr. 17 | Sector Update: Health Care | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+44.92% | 94.22M | |
+9.83% | 115B | |
+10.80% | 105B | |
-10.84% | 22.71B | |
-1.69% | 21.83B | |
-10.90% | 18.18B | |
-41.92% | 16.52B | |
-15.11% | 16.01B | |
+6.62% | 14.14B | |
+17.53% | 10.71B |
- Stock Market
- Equities
- CNTB Stock
- News Connect Biopharma Holdings Limited
- Connect Biopharma Holdings Limited Appoints Chin Lee, MD, MPH as Chief Medical Officer